Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

StatusRecruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Site contact updatedv23
  2. Site contact updatedv22
  3. Site contact updatedv21
  4. Re-verified, no change to tracked fieldsv20
  5. Site contact updatedv19
Show 17 earlier versionsHide 17 earlier versions
  1. Re-verified, no change to tracked fieldsv18
  2. Primary completion date: Jan 2027 to Jan 2030
    • Study completion date: Jan 2028 to Jan 2032
    • Site contact updated
    v17
  3. Site contact updatedv16
  4. Primary completion date: Jan 2023 to Jan 2027
    • Study completion date: Jan 2024 to Jan 2028
    • Site contact updated
    v15
  5. Interventions: Blood draw or skin biopsy (Other) to Blood draw, skin biopsy or urine collection (Other)v14
  6. Re-verified, no change to tracked fieldsv13
  7. Primary completion date: Jan 2022 to Jan 2023
    • Study completion date: Jan 2023 to Jan 2024
    • Site contact updated
    v12
  8. Re-verified, no change to tracked fieldsv11
  9. Eligibility criteria expanded, about 11 words
    • Site contact updated
    • Study description expanded, about 5 words
    • Study title expanded, about 5 words
    v10
  10. Primary endpoint revised
    • Site contact updated
    v9
  11. Primary completion date: Jan 2022
    • Study completion date: Jan 2012 to Jan 2023
    • Site contact updated
    v8
  12. Site contact updatedv7
  13. Study completion date: Jan 2010 to Jan 2012
    • Site contact updated
    v6
  14. Re-verified, no change to tracked fieldsv5
  15. Study Status, Sponsor/Collaborators, Oversight, Study Design, Arms and Interventions, Eligibilityv4
  16. Site contact updatedv3
  17. Site contact updatedv2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a tissue, urine, and blood banking protocol for cutaneous t-cell lymphoma (CTCL), eczema, and atopic dermatitis patients for current and future research.
Trial Details
NCT Number NCT00177268
Lead Sponsor University of Pittsburgh
Conditions
(from sponsor)		 Cutaneous T-cell Lymphoma, Sezary Syndrome, Mycosis Fungoides, Eczema, Atopic Dermatitis
Related terms Dermatitis, Atopic, Eczema, Lymphoma, T-Cell, Cutaneous, Mycosis Fungoides, Sezary Syndrome
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov